Skyrizi and Lymepak drug interactions - a phase IV clinical study of FDA data
Summary:
We study 45,385 people who take Skyrizi (risankizumab-rzaa) and Lymepak (doxycycline hyclate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Skyrizi and Lymepak. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Skyrizi?
Skyrizi has active ingredients of risankizumab-rzaa. eHealthMe is studying from 45,385 Skyrizi users. Check the latest studies of Skyrizi.
What is Lymepak?
Lymepak has active ingredients of doxycycline hyclate.
No report is found.
Do you take Skyrizi and Lymepak?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on risankizumab-rzaa and doxycycline hyclate (the active ingredients of Skyrizi and Lymepak, respectively), and Skyrizi and Lymepak (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Joint Pain and Muscle Rigidity - 2 seconds ago
- Drug interactions of Miralax and Pramipexole Dihydrochloride - 3 seconds ago
- Nausea and Feeling Of Body Temperature Change - 6 seconds ago
- Infusion Related Reaction and drugs of ingredients of hydroxyurea - 9 seconds ago
- Nucynta Er vs. Hydromorphone Hydrochloride, side effect and effectiveness comparison - 11 seconds ago
- Erection Problems and Delirium - 16 seconds ago
- Zantac and Ulcerative Colitis for Women aged 60+ - 23 seconds ago
- Zantac and Colitis Ulcerative for Women aged 60+ - 23 seconds ago
- Zantac and Inflammatory Bowel Disease - Ulcerative Colitis for Women aged 60+ - 23 seconds ago
- Zantac and Uc for Women aged 60+ - 24 seconds ago